X-linked lymphoproliferative syndrome

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • AB2 Bio S.A. Commercial
    TADEKINIG ALFA
    2023-504534-21-00 1 country 2023 n=1 Orphan
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
AB2 Bio S.A. Commercial 1 Phase III 0
New trials by year
2023
1
← All indication landscapes